Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026)
Medtronic recorded quarterly Total Non-Current Liabilities of $40.5 billion in Q1 2026, down 1.05% quarter-over-quarter from $41.0 billion in Q4 2025, and up 4.23% year-over-year from $38.9 billion in Q1 2025.
Medtronic's Total Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $40.5 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 4.23% year-over-year to $40.5 billion; the TTM figure through Jan 2026 stood at $40.5 billion (up 4.23% YoY), while the FY2025 annual figure was $41.8 billion, up 11.0% from the prior year.
- Total Non-Current Liabilities came in at $40.5 billion for Q1 2026 at Medtronic, down from $41.0 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $41.8 billion in Q2 2025 to a low of $36.8 billion in Q2 2022.
- A 5-year average of $39.0 billion and a median of $38.9 billion in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities declined 15.49% in 2022 and increased 11.0% in 2025, its largest moves.
- Medtronic's Total Non-Current Liabilities stood at $40.8 billion in 2022, then declined by 9.68% to $36.9 billion in 2023, then gained by 8.16% to $39.9 billion in 2024, then gained by 2.65% to $41.0 billion in 2025, then slipped by 1.05% to $40.5 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $40.5 billion, $41.0 billion, and $41.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 9.41 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 40.52 Bn |
| Oct 24, 2025 | 40.95 Bn |
| Jul 25, 2025 | 41.03 Bn |
| Apr 25, 2025 | 41.85 Bn |
| Jan 24, 2025 | 38.87 Bn |
| Oct 25, 2024 | 39.89 Bn |
| Jul 26, 2024 | 39.67 Bn |
| Apr 26, 2024 | 37.70 Bn |
| Jan 26, 2024 | 37.43 Bn |
| Oct 27, 2023 | 36.88 Bn |
| Jul 28, 2023 | 37.00 Bn |
| Apr 28, 2023 | 37.56 Bn |
| Jan 27, 2023 | 40.79 Bn |
| Oct 28, 2022 | 40.84 Bn |
| Jul 29, 2022 | 36.88 Bn |
| Apr 29, 2022 | 36.85 Bn |
| Jan 28, 2022 | 37.67 Bn |
| Oct 29, 2021 | 39.33 Bn |
| Jul 30, 2021 | 39.84 Bn |
| Apr 30, 2021 | 41.21 Bn |
| Jan 29, 2021 | 44.57 Bn |
| Oct 30, 2020 | 43.00 Bn |
| Jul 31, 2020 | 40.74 Bn |
| Apr 24, 2020 | 37.14 Bn |
| Jan 24, 2020 | 39.09 Bn |
| Oct 25, 2019 | 38.58 Bn |
| Jul 26, 2019 | 37.90 Bn |
| Apr 26, 2019 | 38.73 Bn |
| Jan 25, 2019 | 35.92 Bn |
| Oct 26, 2018 | 37.71 Bn |
| Jul 27, 2018 | 36.35 Bn |
| Apr 27, 2018 | 37.52 Bn |
| Jan 26, 2018 | 44.50 Bn |
| Oct 27, 2017 | 40.69 Bn |
| Jul 28, 2017 | 48.44 Bn |
| Apr 28, 2017 | 48.01 Bn |
| Jan 27, 2017 | 46.38 Bn |
| Oct 28, 2016 | 46.51 Bn |
| Jul 29, 2016 | 45.92 Bn |
| Apr 29, 2016 | 45.67 Bn |
| Jan 29, 2016 | 50.03 Bn |
| Oct 30, 2015 | 49.91 Bn |
| Jul 31, 2015 | 50.16 Bn |
| Apr 24, 2015 | 50.98 Bn |
| Apr 25, 2014 | 18.27 Bn |